Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-89

First 89 Last

Share
Profile

Follow
BoomCrashOffera

720 Posts.

210

01/02/23

18:04

Post #: 66013114
Share

Originally posted by samfiodiving: ↑

Great News Today

Although it would appear that Anthony Fippis ,s trip to San fran was to no avail as far as investment @ market was concerned ( Failure to create interest @ Market from his recent trip )

Lets hope that behind the scenes he was able to put across to the investment world out there, that he spoke to that, should our Combo trial be succesful, could we look towards an initial onboarding of a fund to the tune of around $6 - $7 mil to take us into a 6 - 9 patient 6 month trial to see the effects of the combo therapy

This would be an initial investment wherby if the small number combo trial is a success then look towards that huge investment from them and backing us into the US market that i have gone on about forever

If i do not see something released within these next 6 - 8 weeks then personally and this is my own personal opinion i will take his overseas trip as being a complete failure, and like he did back in 2011 when he tried to advance 1101 for cancer

As in

Afandin has advised ANP that it has made significant progress in attracting interest in the further development of ATL1101 and is currently in discussions with a number of corporate and investor groups, some of which are currently undertaking due diligence on ATL1101.

THEN SOME 6 MONTHS later after 1 year the agreement was terminated because funds could not be raised

We were informed the market was tough out there

So As was mentioned unlike the above where his efforts had to be reported to market, because he is now a member of ANP as mentioned earlier his discussions and findings will be kept within the inner sanctum we wont know how he went in San Fran

So for me 6 -8 weeks should be long enough to see a major Ann of intent to move this into human trials with investment backing

If he was succesful in San Fran Todays Ann should trigger both sides to get these negotiations underway and plans for clinical trial in motion

That is my run down like i said, the pipe line thus far

Has never let me down.

Its now down to Anthony to deliver on these results,

For once the path forwards has been taken of Marks shoulders

Is he the right man for the Job, well you have my time line

SEE HOW HE GOES

Expand

Hi Sam,

Forgive me if I missed it being mentioned on HC but just noticed Gil Price resigning as CEO of NeuroBo on Jan 18th.

ANP Price at posting: 8.8¢ Sentiment: Hold Disclosure: Held
5 Upvote

1 Great analysis

Reply

Top Stories

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

What's causing the cost-of-living crisis, and how to navigate it

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t